Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:37 a.m.

    📋 AEGLEA BIOTHERAPEUTICS, INC. (AGLE) - Regulatory Update

    Filing Date: 2022-06-08

    Accepted: 2022-06-08 16:05:36

    Event Type: Regulatory Update

    Event Details:

    Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE) Announces Regulatory Update Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE)) (AGLE) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Aeglea BioTherapeutics Inc (was renamed to Spyre Therapeutics (SYRE))
    • CIK: 0001636282
    • Ticker Symbol: AGLE
    • Period End Date: 2022-06-07
    • Document Type: 8-K

Search

News categories